The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Angiography Injectors Market Research Report 2025
Synopsis
The global Angiography Injectors market was valued at US$ 1504.7 million in 2023 and is anticipated to reach US$ 1979.1 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiography Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiography Injectors.
Report Scope
The Angiography Injectors market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiography Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiography Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bayer AG(Medrad Inc.)
Bracco Imaging
Guerbet Group
Ulrich
Nemoto Kyorindo
Sino Medical-Device Technology
Apollo RT
Vivid Imaging
Angiodynamics(Navilyst Medical
Segment by Type
Single-head Angiography Injectors
Dual-head Angiography Injectors
Segment by Application
Central Nervous System Disease
Cardiac Macrovascular Disease
Peripheral Vascular Disease
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiography Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiography Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Angiography Injectors market was valued at US$ 1504.7 million in 2023 and is anticipated to reach US$ 1979.1 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiography Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiography Injectors.
Report Scope
The Angiography Injectors market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiography Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiography Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bayer AG(Medrad Inc.)
Bracco Imaging
Guerbet Group
Ulrich
Nemoto Kyorindo
Sino Medical-Device Technology
Apollo RT
Vivid Imaging
Angiodynamics(Navilyst Medical
Segment by Type
Single-head Angiography Injectors
Dual-head Angiography Injectors
Segment by Application
Central Nervous System Disease
Cardiac Macrovascular Disease
Peripheral Vascular Disease
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiography Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiography Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Angiography Injectors Market Overview
1.1 Product Overview and Scope of Angiography Injectors
1.2 Angiography Injectors Segment by Type
1.2.1 Global Angiography Injectors Market Value Comparison by Type (2024-2030)
1.2.2 Single-head Angiography Injectors
1.2.3 Dual-head Angiography Injectors
1.3 Angiography Injectors Segment by Application
1.3.1 Global Angiography Injectors Market Value by Application: (2024-2030)
1.3.2 Central Nervous System Disease
1.3.3 Cardiac Macrovascular Disease
1.3.4 Peripheral Vascular Disease
1.4 Global Angiography Injectors Market Size Estimates and Forecasts
1.4.1 Global Angiography Injectors Revenue 2019-2030
1.4.2 Global Angiography Injectors Sales 2019-2030
1.4.3 Global Angiography Injectors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Angiography Injectors Market Competition by Manufacturers
2.1 Global Angiography Injectors Sales Market Share by Manufacturers (2019-2024)
2.2 Global Angiography Injectors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Angiography Injectors Average Price by Manufacturers (2019-2024)
2.4 Global Angiography Injectors Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Angiography Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Angiography Injectors, Product Type & Application
2.7 Angiography Injectors Market Competitive Situation and Trends
2.7.1 Angiography Injectors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Angiography Injectors Players Market Share by Revenue
2.7.3 Global Angiography Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Angiography Injectors Retrospective Market Scenario by Region
3.1 Global Angiography Injectors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Angiography Injectors Global Angiography Injectors Sales by Region: 2019-2030
3.2.1 Global Angiography Injectors Sales by Region: 2019-2024
3.2.2 Global Angiography Injectors Sales by Region: 2025-2030
3.3 Global Angiography Injectors Global Angiography Injectors Revenue by Region: 2019-2030
3.3.1 Global Angiography Injectors Revenue by Region: 2019-2024
3.3.2 Global Angiography Injectors Revenue by Region: 2025-2030
3.4 North America Angiography Injectors Market Facts & Figures by Country
3.4.1 North America Angiography Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Angiography Injectors Sales by Country (2019-2030)
3.4.3 North America Angiography Injectors Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Angiography Injectors Market Facts & Figures by Country
3.5.1 Europe Angiography Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Angiography Injectors Sales by Country (2019-2030)
3.5.3 Europe Angiography Injectors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Angiography Injectors Market Facts & Figures by Country
3.6.1 Asia Pacific Angiography Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Angiography Injectors Sales by Country (2019-2030)
3.6.3 Asia Pacific Angiography Injectors Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Angiography Injectors Market Facts & Figures by Country
3.7.1 Latin America Angiography Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Angiography Injectors Sales by Country (2019-2030)
3.7.3 Latin America Angiography Injectors Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Angiography Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Angiography Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Angiography Injectors Sales by Country (2019-2030)
3.8.3 Middle East and Africa Angiography Injectors Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Angiography Injectors Sales by Type (2019-2030)
4.1.1 Global Angiography Injectors Sales by Type (2019-2024)
4.1.2 Global Angiography Injectors Sales by Type (2025-2030)
4.1.3 Global Angiography Injectors Sales Market Share by Type (2019-2030)
4.2 Global Angiography Injectors Revenue by Type (2019-2030)
4.2.1 Global Angiography Injectors Revenue by Type (2019-2024)
4.2.2 Global Angiography Injectors Revenue by Type (2025-2030)
4.2.3 Global Angiography Injectors Revenue Market Share by Type (2019-2030)
4.3 Global Angiography Injectors Price by Type (2019-2030)
5 Segment by Application
5.1 Global Angiography Injectors Sales by Application (2019-2030)
5.1.1 Global Angiography Injectors Sales by Application (2019-2024)
5.1.2 Global Angiography Injectors Sales by Application (2025-2030)
5.1.3 Global Angiography Injectors Sales Market Share by Application (2019-2030)
5.2 Global Angiography Injectors Revenue by Application (2019-2030)
5.2.1 Global Angiography Injectors Revenue by Application (2019-2024)
5.2.2 Global Angiography Injectors Revenue by Application (2025-2030)
5.2.3 Global Angiography Injectors Revenue Market Share by Application (2019-2030)
5.3 Global Angiography Injectors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Angiography Injectors Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bayer AG(Medrad Inc.)
6.2.1 Bayer AG(Medrad Inc.) Corporation Information
6.2.2 Bayer AG(Medrad Inc.) Description and Business Overview
6.2.3 Bayer AG(Medrad Inc.) Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer AG(Medrad Inc.) Angiography Injectors Product Portfolio
6.2.5 Bayer AG(Medrad Inc.) Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bracco Imaging Angiography Injectors Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guerbet Group Angiography Injectors Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Ulrich
6.5.1 Ulrich Corporation Information
6.5.2 Ulrich Description and Business Overview
6.5.3 Ulrich Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ulrich Angiography Injectors Product Portfolio
6.5.5 Ulrich Recent Developments/Updates
6.6 Nemoto Kyorindo
6.6.1 Nemoto Kyorindo Corporation Information
6.6.2 Nemoto Kyorindo Description and Business Overview
6.6.3 Nemoto Kyorindo Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nemoto Kyorindo Angiography Injectors Product Portfolio
6.6.5 Nemoto Kyorindo Recent Developments/Updates
6.7 Sino Medical-Device Technology
6.6.1 Sino Medical-Device Technology Corporation Information
6.6.2 Sino Medical-Device Technology Description and Business Overview
6.6.3 Sino Medical-Device Technology Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sino Medical-Device Technology Angiography Injectors Product Portfolio
6.7.5 Sino Medical-Device Technology Recent Developments/Updates
6.8 Apollo RT
6.8.1 Apollo RT Corporation Information
6.8.2 Apollo RT Description and Business Overview
6.8.3 Apollo RT Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Apollo RT Angiography Injectors Product Portfolio
6.8.5 Apollo RT Recent Developments/Updates
6.9 Vivid Imaging
6.9.1 Vivid Imaging Corporation Information
6.9.2 Vivid Imaging Description and Business Overview
6.9.3 Vivid Imaging Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vivid Imaging Angiography Injectors Product Portfolio
6.9.5 Vivid Imaging Recent Developments/Updates
6.10 Angiodynamics(Navilyst Medical
6.10.1 Angiodynamics(Navilyst Medical Corporation Information
6.10.2 Angiodynamics(Navilyst Medical Description and Business Overview
6.10.3 Angiodynamics(Navilyst Medical Angiography Injectors Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Angiodynamics(Navilyst Medical Angiography Injectors Product Portfolio
6.10.5 Angiodynamics(Navilyst Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Angiography Injectors Industry Chain Analysis
7.2 Angiography Injectors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Angiography Injectors Production Mode & Process
7.4 Angiography Injectors Sales and Marketing
7.4.1 Angiography Injectors Sales Channels
7.4.2 Angiography Injectors Distributors
7.5 Angiography Injectors Customers
8 Angiography Injectors Market Dynamics
8.1 Angiography Injectors Industry Trends
8.2 Angiography Injectors Market Drivers
8.3 Angiography Injectors Market Challenges
8.4 Angiography Injectors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
